A review found selenium supplements in daily dosages of 100300 mcg led to improved thyroid function at 6 months in people with Graves disease, but this effect was lost at 9 months (34)
2025, e70103, Rentzeperi, Elpiniki, et al
For patients with heart failure or chronic kidney disease, SGLT2 inhibitors are generally preferred first, with GLP-1 agonists considered when SGLT2 inhibitors are contraindicated or not tolerated
Venugopal S, MD, Issa GC, MD, Konopleva M, MD, PhD, DiNardo CD, MD, MSCE, Borthakur G, MD, Jabbour EJ, MD, Pemmaraju N, MD, Yilmaz M, MD, Short NJ, MD, Maiti A, MBBS, Sasaki K, MD, PhD, Masarova L, MD, Pierce SA, BSN, BA, Takahashi K, MD, PhD, Tang G, MD, PhD, Loghavi S, MD, Andreeff M , MD, PhD, Bhalla KN, MD, Garcia-Manero G, MD, Ravandi F, MBBS, Kantarjian H, MD, Daver N, MD